Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Ginkgo Bioworks
DNA
Concentration Risk %
Concentration Risk % at other companies
Burlington Stores
BURL
5%
0.0pp
Burlington Stores
BURL
0.8%
0.0pp
Ulta Beauty, Inc.
ULTA
40%
0.0pp
Ulta Beauty, Inc.
ULTA
4%
0.0pp
Ulta Beauty, Inc.
ULTA
24%
-1.0pp
Expro Group Holdings
XPRO
4.8%
+0.4pp
Segments
By product
See full
Government and defense
45%
+114%
Agriculture
20%
-13.0%
Pharmaceutical and biotechnology
20%
—
Food and nutrition
7%
+16.7%
Consumer and technology
6%
+200%
Industrial and environment
2%
-50.0%
By segment
See full
Cell Engineering
15%
-25.0%
Biosecurity
12%
-25.0%
By geography
See full
UNITED STATES
83%
+5.1%
DENMARK
13%
+18.2%
Other financials
Income statement
See full
Revenue
$20.2M
-48.5%
Gross profit
$18.4M
-45.4%
Operating income
-$58.5M
-0.7%
Net income
-$46.7M
+22.5%
EPS (diluted)
-$1.42
+27.6%
Balance sheet
See full
Cash & equivalents
$172.0M
-31.6%
Total debt
$404.1M
-5.8%
Total equity
$420.3M
-31.4%
Total assets
$990.0M
-19.6%
Cash flow
See full
Operating cash flow
-$44.3M
-10.0%
CapEx
$2.6M
+6,792%
Free cash flow
-$46.9M
-16.4%
Valuation
See full
Market cap
$515.15M
-26.8%
Enterprise value
$747.25M
-15.2%
P/S
4.6×
+1.3×
Profitability
See full
Gross margin
91.8%
—
Operating margin
-259.9%
+1,304pp
Net margin
-260%
+718pp
FCF margin
-156.3%
+38.7pp
Returns & leverage
See full
Return on equity
-56.3%
+23.1pp
Debt / equity
1×
+0.3×
Current ratio
4.6×
-0.8×
Watchlist
Screener
Filings
Earnings
Charts